Online Pharmaceutical Schedule - November 2019
Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator
Maximum of two doses for patients meeting the following:
first dose to be administered in infants aged under 14 weeks of age; and
no vaccination being administered to children aged 24 weeks or over.